Opexa Therapeutics (OPXA +12%) moves up today after disclosing that Nasdaq regulators earlier this week agreed to postpone a possible delisting until May 15 after it files its quarterly report for the three months ending March 31. According to its regulatory filing, OPXA was given 45 days to present a plan to regain compliance.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs